Inefficient TLR4/MD-2 heterotetramerization by monophosphoryl lipid A

Area of Science:

• Immunology
• Molecular Biology

Background:

• Toll-like receptor 4 (TLR4) signaling is activated by lipopolysaccharide (LPS) and bifurcates into MyD88-dependent and TRIF-dependent pathways.
• Monophosphoryl lipid A (MPLA) and diphosphoryl lipid A (DLA) are lipid A structures that differentially activate TLR4 signaling.
• Synthetic monophosphoryl lipid A (sMLA) and diphosphoryl lipid A (sDLA) provide tools to dissect TLR4 activation mechanisms.

Purpose of the Study:

• To investigate the molecular mechanisms underlying the differential activation of TLR4 signaling by sMLA and sDLA.
• To determine how sMLA's structural difference impacts downstream signaling events, including protein recruitment and receptor complex formation.
• To assess whether the observed effects with synthetic MPLA extend to biologically derived MPLA.

Main Methods:

• Compared the ability of sMLA and sDLA to recruit TNF receptor-associated factor 6 (TRAF6) to Interleukin-1 receptor-associated kinase 1 (IRAK1) in TLR4/MyD88 signaling.
• Utilized the MTS510 antibody to assess TLR4/Myeloid differentiation factor 2 (MD-2) heterotetramer formation.
• Employed a F126A mutant of MD-2 to investigate the role of heterotetramerization in sMLA-induced signaling.
• Examined TLR4/MD-2 heterotetramer formation in cells treated with both synthetic and biologically derived monophosphoryl lipid A (MPLA).

Main Results:

• sMLA showed significantly reduced recruitment of TRAF6 to IRAK1 compared to sDLA, indicating impaired MyD88-dependent signaling downstream of TLR4.
• sMLA did not efficiently induce TLR4/MD-2 heterotetramer formation, as indicated by MTS510 antibody staining, unlike sDLA.
• While sMLA signaling is generally weak, it still requires TLR4/MD-2 heterotetramer formation for maximal activity, even when lipid A binding is possible.
• Reduced TLR4/MD-2 heterotetramer formation was observed with both synthetic and biologically derived MPLA, suggesting a general property of monophosphorylated lipid A.

Conclusions:

• The weak activation of MyD88-dependent TLR4 signaling by sMLA is attributed to its inability to efficiently recruit TRAF6 and form TLR4/MD-2 heterotetramers.
• Monophosphorylation of lipid A significantly impairs TLR4/MD-2 heterotetramerization, leading to reduced downstream signaling.
• These findings highlight the structural requirements for potent TLR4 activation and provide insights into the differential immunomodulatory effects of various lipid A forms.